NeuroBo Pharmaceuticals Inc (NRBO)
4.40
-0.20
(-4.35%)
USD |
NASDAQ |
May 21, 16:00
4.40
0.00 (0.00%)
After-Hours: 16:22
NeuroBo Pharmaceuticals Cash from Operations (Quarterly): -6.442M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -6.442M |
| December 31, 2023 | -3.393M |
| September 30, 2023 | -2.814M |
| June 30, 2023 | -2.045M |
| March 31, 2023 | -2.547M |
| December 31, 2022 | -1.807M |
| September 30, 2022 | -2.359M |
| June 30, 2022 | -2.717M |
| March 31, 2022 | -4.829M |
| December 31, 2021 | -2.899M |
| September 30, 2021 | -2.507M |
| June 30, 2021 | -3.587M |
| March 31, 2021 | -6.141M |
| December 31, 2020 | -2.348M |
| September 30, 2020 | -1.954M |
| June 30, 2020 | -2.324M |
| March 31, 2020 | -4.138M |
| December 31, 2019 | -1.278M |
| September 30, 2019 | -3.345M |
| Date | Value |
|---|---|
| June 30, 2019 | -1.192M |
| March 31, 2019 | -1.224M |
| December 31, 2018 | 3.347M |
| September 30, 2018 | -4.284M |
| June 30, 2018 | -6.278M |
| March 31, 2018 | -7.236M |
| December 31, 2017 | -6.76M |
| September 30, 2017 | -7.299M |
| June 30, 2017 | -6.619M |
| March 31, 2017 | -6.223M |
| December 31, 2016 | -3.623M |
| September 30, 2016 | -3.634M |
| June 30, 2016 | -1.73M |
| March 31, 2016 | -2.056M |
| December 31, 2015 | -2.256M |
| September 30, 2015 | -1.562M |
| June 30, 2015 | -0.995M |
| March 31, 2015 | -0.62M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-6.442M
Minimum
Mar 2024
-1.192M
Maximum
Jun 2019
-3.033M
Average
-2.632M
Median
Cash from Operations (Quarterly) Benchmarks
| Eli Lilly and Co | 1.166B |
| SIGA Technologies Inc | -6.118M |
| Vanda Pharmaceuticals Inc | 7.569M |
| Tenon Medical Inc | -2.338M |
| NovaBay Pharmaceuticals Inc | -1.572M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.005M |
| Free Cash Flow | -14.74M |
| Free Cash Flow Per Share (Quarterly) | -1.267 |
| Free Cash Flow Yield | -65.98% |